Introduction
Tobacco smoke is an established risk factor for Crohn’s disease (CD) postoperative recurrence (POR), however, the effect of e-cigarettes and heat-not-burn tobacco (HNBT) remains unknown. We aimed to evaluate the impact of e-cigarettes and HNBT on postoperative recurrence in CD patients.
Aims & Methods
We retrospectively included consecutive CD patients who underwent ileocolic resection and endoscopic evaluation between 6 and 12 months after surgery across 9 centers in Italy, Spain, and France. Based on smoking habits between surgery and endoscopy, patients were categorized as non-smokers, cigarette smokers, HNBT users, or e-cigarette users. To avoid confounding, the use of HNBT and e-cigarettes was confirmed by phone call, and patients smoking multiple products were excluded.
The primary outcome was endoscopic recurrence (Rutgeerts score ≥2) within the first year. Secondary analyses were conducted on the population receiving prophylactic treatment, using the modified Rutgeerts score (≥i2b), the mean Rutgeerts score, transmural disease activity, fecal calprotectin, time from diagnosis to surgery, and multivariable regression analysis.
Results
In total, 1157 patients were included, of which 860 (75%) were non-smokers, 220 (19%) conventional cigarette smokers, 37 (3%) HNBT users, and 33 (3%) e-cigarette users. Groups were homogeneous for most clinical and demographic variables, including a history of intestinal surgery for CD, use of biologics in the 12 months before surgery, and prescription of POR prophylaxis, but not age. HNBT users were younger than other groups.
Recurrence rates were significantly higher in all smoking groups compared to non-smokers: 70%, 69%, and 68% for e-cigarette, HNBT, and cigarette users, respectively, vs. 39% for non-smokers; all p<0.01. The association persisted in patients receiving pharmacological prophylaxis, with 75%, 69%, 70%, and 40% recurrence for the same groups, and all comparisons remaining significant (all p<0.005).
Using the modified Rutgeerts score cutoff of i2b to define POR overall rates decreased, with 57% recurrence for e-cigarette and HNBT users, 54% for conventional cigarette smokers, and 29% for non-smokers. However, the relative proportions remained consistent, and the differences between groups did not change.
When analyzing the Rutgeerts score as a continuous variable, traditional cigarette smoking, HNBT use, and e-cigarette use remained associated with significantly greater endoscopic disease activity compared to non-smokers (2.02, 2.09, and 1.7,4 respectively, vs. 1.12; all p<0.05). Interestingly, the mean Rutgeerts score among e-cigarette users was numerically lower than that of conventional tobacco cigarettes and HNBT, although the difference was not statistically significant (1.74 vs. 2.02 and 2.09, respectively, both p>0.05). When restricting the analysis to patients receiving prophylactic biologics, differences persisted (p<0.05).
The average fecal calprotectin levels and imaging assessments confirmed the trends observed in endoscopy. The mean calprotectin levels at the time of endoscopy were 221 μ/g, 206 μ/g and 174 μ/g for tobacco, HNBT, and e-cigarettes, respectively, vs. 124 μ/g in non-smokers. Rates of transmural remission were 35%, 48%, 56%, and 61% for the same groups, respectively. Nevertheless, in calprotectin and radiologic analyses, only the differences between conventional smokers and non-smokers reached statistical significance (p<0.05), possibly due to the limited availability of these data and the wide variability of calprotectin levels.
After accounting for potential confounders such as sex, location and behavior of disease at diagnosis, disease duration, type of anastomosis, and previous intestinal resections, all smoking groups remained significantly associated with an increased risk of endoscopic recurrence compared to nonsmokers, e-cigarette (OR 3.06, 95% CI 1.08-9.57, p=0.041), and HNBT (OR 4.47, 95% CI 2.00-10.77, p<0.001), and conventional tobacco (OR 4.66, 95% CI 3.07-7.20, p<0.001).
Finally, we compared disease duration at the time of surgery. Compared to those who never smoked, patients who smoked traditional cigarettes and used HNBT had a significantly shorter disease duration at the time of intervention (7.2 and 5.2 years vs 9.0; p=0.029 and p=0.046, respectively), suggestive of a more aggressive disease course. Instead, the difference with e-cigarettes was not significant (7.5 years vs 9.0, p=0.76).
Conclusion
E-cigarettes and heat-not-burn tobacco are associated with increased endoscopic recurrence of CD compared to non-smoking.